Concerning the IL-17A, in a single study Zebrowska et al. documented significantly higher expression of this cytokine in the epidermis (perilesional skin) and the serum of DH and bullous pemphigoid patients, compared to the control group [41]. This evidence concerns the gene IL17A and bullous pemphigoid.